Biobusiness Development
Think Europe, think Biovalley!
In the heart of Europe, bringing together three regions from France, Germany and Switzerland, BioValley is one of the leading European Life Sciences regions in the world. Are you developing innovative projects in Life Sciences or wishing to locate in Europe, come and meet the BioValley Cluster!
-
HORIZON 2020 – NEW BIOINFORMATICS APPROACHES IN THE SERVICE OF BIOTECHNOLOGY
One of the greatest challenge facing the biotechnology community today is to be able to make use of the vast and dynamic influx of “omics” data. The synchronised development of bioinformatic concepts and related computational tools for prediction and modelling is a prerequisite. In this context proposals should develop innovate bioinformatics approaches to close the gap between data availibility and the descovery of new biotechnological applications. The deadline for submitting proposals is February 24th, 2015. -
SURFACE TECHNOLOGIES FOR MEDICAL DEVICES
The program features short presentations from industrial and academic scientists in front of an professional audience (industry and academia). Lunch and coffee breaks invite the participants to exchange ideas and to discuss. The audience will have the opportunity to briefly introduce their company / research group in a 2-3 minute presentation. Time: 10th of July 2014 / Place: Novotel Karlsruhe Germany. This Meet&Match is coorganised by Bio-Pro GmbH and Alsace BioValley. -
FREIBURG SCIENTIST IS AWARDED THE PAUL EHRLICH PRIZE 2014
Prof. Dr Michael Ret
h has won the Paul Ehrlich and Ludwig Darmstaedter Prize 2014 for his research on the immune system. Dr Reth is Professor for Molecular Immunology at the Institute of Biology III of the University of Freiburg and Scientific Director of the Cluster of Excellence BIOSS. He is also head of the department for Molecular Immunology at the Max Planck Institute of Immunobiology and Epigenetics (MPI-IE). This prize is endowed with € 100,000 and is one of the highest honours in science in Germany. -
Rhenovia Pharma secures Series B funding
The company raises EUR 540,000 (USD 738, 000) from historical shareholders to expand its staff Rhenovia, the world leader in biosimulation of the central nervous system, plans to raise a further EUR 2 million in 2014 to step up development in its three key markets of medicinal products, agrifood and neurotoxicity -
MICHAEL N. HALL, PROFESSOR AT THE UNIVERSITY OF BASEL’S BIOZENTRUM AWARDED THIS YEAR’S MARCEL BENOIST PRIZE
The prize is being awarded to Hall for his ground-breaking studies in the field of cell biology on cell growth and the development of cancer. As a young assistant professor at the Biozentrum in the 1990′s, Hall discovered a protein that controls cell growth and size in the context of his work on simple organisms, in particular yeasts. It soon became clear to him that this mechanism was also present in complex organisms such as mammals and humans and was vital to the life processes of cells and organs.
BioValley
the Place to be
BioValley is teeming with advantages for all players in Life Sciences who are searching to settle down and develop in the European BioValley region.
Discover BioValley
Players Database!
BioValley offers a unique combination of scientific talents in academia as well as in industry.
Let’s discover all BioValley key players through our online Database!
BioValley
Services & Events
The BioValley cluster is your one-stop contact for all project development and locating in the BioValley region. Discover how BioValley can help you and take part to our network / business events: see our annual event schedule!
